http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-63102-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 1996-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c438972b4eb7a407ad54eaa0d42eea0f
publicationDate 2001-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-63102-B1
titleOfInvention USE OF BISPHOSPHONATES FOR INHIBITATION OF BONE RESARTMENT AFTER IMPLANTATION OF ORTHOPEDIC PROTECTION
abstract The invention relates to a method of treating and preventing periprosthetic bone loss by administering a bisphosphonate inhibitor of bone resorption, for example alendronate, in patients with an orthopedic implant.
priorityDate 1994-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503883
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ27957
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152749113
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ7TQD2
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407935929
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57637
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3T478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577472
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO94811
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419499821
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419532918
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID405383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415728701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25419
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23957
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJC5
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408184029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419494003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415958069
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD3ZQL7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420241340
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554994
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VV43
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCC0HJD2

Total number of triples: 56.